SignatureFD’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
SignatureFD's LGND Position: Q3 2026 in Review
SignatureFD reduced its Ligand Pharmaceuticals (LGND) stake by 2.5% in Q3 2026, selling an estimated $2.07K and leaving 276 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.
SignatureFD first reported a position in LGND in Q3 2018 and has held it in 28 quarters since. The position peaked at $206K in Q3 2018. 434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- SignatureFD held 276 shares of Ligand Pharmaceuticals worth $86.2K as of Q3 2026.
- SignatureFD sold 7 Ligand Pharmaceuticals shares in Q3 2026, an estimated $2.07K.
- Ligand Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1640 holding.
- SignatureFD first reported a position in Ligand Pharmaceuticals in Q3 2018 and has held it in 28 quarters since.
- SignatureFD's Ligand Pharmaceuticals position peaked at $206K in Q3 2018.
- 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.